Back to top
more

MEDIFAST (MED)

(Delayed Data from NYSE)

$25.72 USD

25.72
338,667

+0.76 (3.04%)

Updated May 9, 2024 04:00 PM ET

After-Market: $25.71 -0.01 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (86 out of 250)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Sanghamitra Saha headshot

Explore DuPont Analysis & Pick 5 Top Stocks

by Sanghamitra Saha

Do you have more faith in DuPont analysis than simple ROE calculation? Tap UFP Industries (UFPI), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).

    Sanghamitra Saha headshot

    Dive Into DuPont Analysis & Pick 5 Top Stocks

    by Sanghamitra Saha

    Do you have more faith in DuPont analysis than simple ROE calculation? Tap Sanderson Farms (SAFM), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).

      Pilgrim's Pride (PPC) Q2 Earnings Beat, Sales Improve Y/Y

      by Zacks Equity Research

      Pilgrim's Pride's (PPC) second-quarter 2022 results reflect increased earnings and sales on growth across Mexico and Europe and the U.S. operations.

      Hershey (HSY) Beats on Q2 Earnings & Sales, Raises 2022 View

      by Zacks Equity Research

      Hershey's (HSY) second-quarter 2022 results reflect higher earnings and sales on growth across all segments. Management raises 2022 guidance.

      Medifast (MED) is a Top Dividend Stock Right Now: Should You Buy?

      by Zacks Equity Research

      Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes? Let's find out.

      Are Investors Undervaluing Greencore Group (GNCGY) Right Now?

      by Zacks Equity Research

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

      Kraft Heinz (KHC) Q2 Earnings Top Estimates, Sales Fall Y/Y

      by Zacks Equity Research

      The Kraft Heinz Company's (KHC) second-quarter 2022 results reflect lower earnings and sales. Nevertheless, management raises the 2022 organic net sales view.

      Kimberly-Clark (KMB) Q2 Earnings Miss Mark, Sales Rise Y/Y

      by Zacks Equity Research

      Kimberly-Clark's (KMB) second-quarter 2022 earnings decline year over year. Nevertheless, sales increase on growth across all segments.

      Inter Parfums (IPAR) Ups 2022 Guidance on Robust Q2 Sales

      by Zacks Equity Research

      Inter Parfums' (IPAR) sales increase year over year in second-quarter 2022. Management raises its top-and bottom-line view for 2022.

      Campbell Soup (CPB) Looks Delectable on Solid Brands & Savings

      by Zacks Equity Research

      Campbell Soup's (CPB) prudent investment and strategic efforts in product innovation and brand building bode well. Also, it is progressing well with cost-saving plans.

      Inter Parfums (IPAR) Partners With G-III Apparel to Fuel Growth

      by Zacks Equity Research

      Inter Parfums (IPAR) finalizes an agreement with G-III Apparel to become the exclusive worldwide licensee for the Donna Karan and DKNY fragrance brands.

      Zacks.com featured highlights Sanderson Farms, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington

      by Zacks Equity Research

      Sanderson Farms, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington have been highlighted in this Screen of the Week article.

      The J.M. Smucker (SJM) Rewards Investors With Dividend Hike

      by Zacks Equity Research

      The J.M. Smucker (SJM) rewards shareholders by raising the quarterly dividend. The company is progressing with core priorities.

      Sanghamitra Saha headshot

      Dive Into DuPont Analysis & Pick 5 Top Stocks

      by Sanghamitra Saha

      Do you have more faith in DuPont analysis than simple ROE calculation? Tap Sanderson Farms (SAFM), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).

      Chefs' Warehouse (CHEF) Soars 5.4%: Is Further Upside Left in the Stock?

      by Zacks Equity Research

      Chefs' Warehouse (CHEF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

      Lamb Weston (LW) Stock Up More Than 15% YTD: Here's Why

      by Zacks Equity Research

      Lamb Weston (LW) benefits from a recovery in the Foodservice business. The company's efforts to boost production capacity and fuel long-term growth are yielding.

      Solid Skin Care Business Aids The Estee Lauder Companies (EL)

      by Zacks Equity Research

      The Estee Lauder Companies (EL) is benefiting from strong e-commerce business. Also, the company's Skin Care portfolio has been performing well.

      Strength in Core Priorities Aid Coty (COTY), High Costs Ail

      by Zacks Equity Research

      Coty (COTY) makes several strategic partnerships to enhance its brand portfolio. However, the company is not immune to the rising inflationary environment.

      Conagra Brands (CAG) Q4 Earnings Beat Estimates

      by Zacks Equity Research

      Conagra Brands (CAG) delivered earnings and revenue surprises of 1.56% and 0.93%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?

      Tyson Foods (TSN) Gains on Solid Brands & Capacity Expansion

      by Zacks Equity Research

      Tyson Foods (TSN) is focused on higher protein production to cater to the rising demand for protein-packed food. Focus on its e-commerce business bodes well.

      This is Why Medifast (MED) is a Great Dividend Stock

      by Zacks Equity Research

      Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes? Let's find out.

      Is MEDIFAST (MED) Stock Undervalued Right Now?

      by Zacks Equity Research

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

      Is Greencore Group (GNCGY) Stock Undervalued Right Now?

      by Zacks Equity Research

      Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

      Why Medifast (MED) is a Top Momentum Stock for the Long-Term

      by Zacks Equity Research

      Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

      Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think "Yes"

      by Zacks Equity Research

      Medifast (MED) could produce exceptional returns because of its solid growth attributes.